Titre : Protéines de fusion virale

Protéines de fusion virale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Preliminary Data
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines de fusion virale : Questions médicales les plus fréquentes", "headline": "Protéines de fusion virale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines de fusion virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-13", "dateModified": "2025-05-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines de fusion virale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines de l'enveloppe virale", "url": "https://questionsmedicales.fr/mesh/D014759", "about": { "@type": "MedicalCondition", "name": "Protéines de l'enveloppe virale", "code": { "@type": "MedicalCode", "code": "D014759", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.964.970.880" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycoprotéine de spicule des coronavirus", "alternateName": "Spike Glycoprotein, Coronavirus", "url": "https://questionsmedicales.fr/mesh/D064370", "about": { "@type": "MedicalCondition", "name": "Glycoprotéine de spicule des coronavirus", "code": { "@type": "MedicalCode", "code": "D064370", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.964.970.880.910.665" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines de fusion virale", "alternateName": "Viral Fusion Proteins", "code": { "@type": "MedicalCode", "code": "D014760", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jiachen Huang", "url": "https://questionsmedicales.fr/author/Jiachen%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia; Athens, GA 30602, USA." } }, { "@type": "Person", "name": "Jarrod J Mousa", "url": "https://questionsmedicales.fr/author/Jarrod%20J%20Mousa", "affiliation": { "@type": "Organization", "name": "Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia; Athens, GA 30602, USA." } }, { "@type": "Person", "name": "Wen Chang", "url": "https://questionsmedicales.fr/author/Wen%20Chang", "affiliation": { "@type": "Organization", "name": "Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan." } }, { "@type": "Person", "name": "Rebecca Ellis Dutch", "url": "https://questionsmedicales.fr/author/Rebecca%20Ellis%20Dutch", "affiliation": { "@type": "Organization", "name": "Department of Molecular and Cellular Biochemistry, University of Kentucky, 741 South Limestone Street, Lexington, KY 40536, USA." } }, { "@type": "Person", "name": "Markus Hoffmann", "url": "https://questionsmedicales.fr/author/Markus%20Hoffmann", "affiliation": { "@type": "Organization", "name": "Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Antibiotic resistance patterns in nosocomial infections: preliminary data from Hospital of Al-Hoceima, Morocco.", "datePublished": "2023-09-30", "url": "https://questionsmedicales.fr/article/37824357", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3855/jidc.17454" } }, { "@type": "ScholarlyArticle", "name": "Relationship between Nutritional Status, Food Consumption and Sarcopenia in Post-Stroke Rehabilitation: Preliminary Data.", "datePublished": "2022-11-15", "url": "https://questionsmedicales.fr/article/36432512", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/nu14224825" } }, { "@type": "ScholarlyArticle", "name": "An agile, data-driven approach for target selection in rTMS therapy for anxiety symptoms: Proof of concept and preliminary data for two novel targets.", "datePublished": "2023-03-22", "url": "https://questionsmedicales.fr/article/36949668", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/brb3.2914" } }, { "@type": "ScholarlyArticle", "name": "Pulsed-Field Ablation on Mitral Isthmus in Persistent Atrial Fibrillation: Preliminary Data on Efficacy and Safety.", "datePublished": "2023-06-21", "url": "https://questionsmedicales.fr/article/37354173", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jacep.2023.03.021" } }, { "@type": "ScholarlyArticle", "name": "Normative Reference Values for FEES and VASES: Preliminary Data From 39 Nondysphagic, Community-Dwelling Adults.", "datePublished": "2023-06-21", "url": "https://questionsmedicales.fr/article/37343540", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2023_JSLHR-23-00132" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines virales", "item": "https://questionsmedicales.fr/mesh/D014764" }, { "@type": "ListItem", "position": 5, "name": "Protéines virales structurales", "item": "https://questionsmedicales.fr/mesh/D015678" }, { "@type": "ListItem", "position": 6, "name": "Protéines de l'enveloppe virale", "item": "https://questionsmedicales.fr/mesh/D014759" }, { "@type": "ListItem", "position": 7, "name": "Protéines de fusion virale", "item": "https://questionsmedicales.fr/mesh/D014760" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines de fusion virale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines de fusion virale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines de fusion virale", "description": "Comment diagnostiquer une infection virale liée aux protéines de fusion ?\nQuels tests sont utilisés pour détecter les protéines de fusion ?\nLes biopsies sont-elles utiles pour le diagnostic ?\nQuels symptômes peuvent indiquer une infection virale ?\nLes tests d'imagerie sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines de fusion virale", "description": "Quels sont les symptômes courants d'une infection virale ?\nLes symptômes varient-ils selon le virus ?\nLes symptômes peuvent-ils être graves ?\nComment les symptômes évoluent-ils avec le temps ?\nLes symptômes sont-ils similaires à ceux d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines de fusion virale", "description": "Comment prévenir les infections virales ?\nLes masques aident-ils à prévenir la transmission virale ?\nLes voyages augmentent-ils le risque d'infection virale ?\nL'alimentation influence-t-elle la prévention des infections ?\nLes mesures de distanciation sociale sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines de fusion virale", "description": "Quels traitements sont disponibles pour les infections virales ?\nLes antibiotiques sont-ils efficaces contre les infections virales ?\nLa vaccination peut-elle prévenir les infections virales ?\nLes traitements varient-ils selon le type de virus ?\nLes traitements sont-ils efficaces contre toutes les souches virales ?", "url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines de fusion virale", "description": "Quelles sont les complications possibles des infections virales ?\nLes complications varient-elles selon le virus ?\nComment prévenir les complications des infections virales ?\nLes complications peuvent-elles être mortelles ?\nLes personnes âgées sont-elles plus à risque de complications ?", "url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines de fusion virale", "description": "Quels sont les principaux facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes contacts avec des animaux peuvent-ils être un facteur de risque ?\nLes conditions de vie en collectivité augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection virale liée aux protéines de fusion ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sérologiques et des cultures virales." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les protéines de fusion ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests ELISA et des techniques de PCR peuvent être utilisés pour détecter ces protéines." } }, { "@type": "Question", "name": "Les biopsies sont-elles utiles pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les biopsies peuvent aider à identifier des infections virales spécifiques." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une infection virale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, éruptions cutanées et douleurs musculaires peuvent être des indicateurs." } }, { "@type": "Question", "name": "Les tests d'imagerie sont-ils nécessaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Généralement non, mais ils peuvent être utilisés pour évaluer des complications." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une infection virale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, toux, fatigue, douleurs musculaires et éruptions cutanées sont fréquents." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le virus ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son type." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être graves ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections virales peuvent entraîner des complications graves." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec le temps ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent s'aggraver ou s'améliorer selon la réponse immunitaire de l'hôte." } }, { "@type": "Question", "name": "Les symptômes sont-ils similaires à ceux d'autres maladies ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être confondus avec ceux de maladies bactériennes ou auto-immunes." } }, { "@type": "Question", "name": "Comment prévenir les infections virales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination, l'hygiène des mains et l'évitement des contacts sont essentiels." } }, { "@type": "Question", "name": "Les masques aident-ils à prévenir la transmission virale ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les masques peuvent réduire la transmission des virus respiratoires." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection virale ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque d'infection." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle la prévention des infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée renforce le système immunitaire et aide à prévenir les infections." } }, { "@type": "Question", "name": "Les mesures de distanciation sociale sont-elles efficaces ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles réduisent la propagation des infections virales dans la communauté." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les infections virales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux, les soins de soutien et les traitements symptomatiques sont courants." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre les infections virales ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les virus, seulement contre les bactéries." } }, { "@type": "Question", "name": "La vaccination peut-elle prévenir les infections virales ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent prévenir des infections virales spécifiques." } }, { "@type": "Question", "name": "Les traitements varient-ils selon le type de virus ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virus peut nécessiter un traitement spécifique adapté à son mécanisme." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces contre toutes les souches virales ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, certaines souches peuvent être résistantes aux traitements disponibles." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des infections virales ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Pneumonie, encéphalite et défaillance organique sont des complications graves." } }, { "@type": "Question", "name": "Les complications varient-elles selon le virus ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virus peut entraîner des complications spécifiques selon son tropisme." } }, { "@type": "Question", "name": "Comment prévenir les complications des infections virales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement précoce et une surveillance médicale peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Les complications peuvent-elles être mortelles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent entraîner la mort si elles ne sont pas traitées rapidement." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque de complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de complications graves liées aux infections virales." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection virale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'immunodépression, le vieillissement et les conditions de santé préexistantes augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'infection ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire le risque d'infections virales." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à forte prévalence virale augmente le risque d'infection." } }, { "@type": "Question", "name": "Les contacts avec des animaux peuvent-ils être un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains virus zoonotiques peuvent être transmis par contact avec des animaux infectés." } }, { "@type": "Question", "name": "Les conditions de vie en collectivité augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les environnements surpeuplés favorisent la transmission des infections virales." } } ] } ] }

Sources (10000 au total)

Antibiotic resistance patterns in nosocomial infections: preliminary data from Hospital of Al-Hoceima, Morocco.

Nosocomial infections or healthcare-associated infections (HCAIs) represent a public health problem. The burden of antibiotic resistance in these infections is still unclear in Morocco. The objective ... Data were collected from 1519 laboratory records including hospital inpatients suspected of nosocomial infections in Mohamed V Hospital of Al-Hoceima between January 2016 and December 2020. The data w... Bacteriological test samples included 65.5% of urine, 27.2% of pleural fluid, 4.5% of pus, and 2.8% of protected distal swab. Two hundred and twenty-seven (15%) samples were culture-positive. The bact... Our results showed a higher frequency of resistance. A microbiological surveillance system is highly needed to identify bacterial niches in the hospital environment at Mohamed V Hospital....

An agile, data-driven approach for target selection in rTMS therapy for anxiety symptoms: Proof of concept and preliminary data for two novel targets.

Data-driven approaches to transcranial magnetic stimulation (TMS) might yield more consistent and symptom-specific results based on individualized functional connectivity analyses compared to previous... We used the resting-state functional MRI data of 28 patients with medically refractory generalized anxiety disorder to perform agile target selection based on abnormal functional connectivity patterns... Areas 8Av and PGs demonstrated consistent abnormalities, particularly in the left hemisphere. Significant improvements were demonstrated in anxiety symptoms, and few, minor complications were reported... Our study suggests that a left-lateralized DMN is likely the primary functional network disturbed in anxiety-related disorders, which can be improved by identifying and targeting abnormal regions with...

Pulsed-Field Ablation on Mitral Isthmus in Persistent Atrial Fibrillation: Preliminary Data on Efficacy and Safety.

Pulsed-field ablation (PFA) is a new and promising modality of ablation that has been shown to specifically ablate cardiac tissue while sparing other anatomic structures, thus avoiding thermal ablatio... The purpose of this study was to evaluate the feasibility and safety of mitral isthmus (MI) ablation in addition to PVI and posterior wall (PW) ablation with PFA in patients with persistent AF.... We prospectively included all consecutive patients with persistent AF who underwent a first ablation procedure with PFA. We performed in all these patients a substrate ablation strategy comprising PVI... From November 2021 to September 2022, we included 45 patients. Complete MI block was achieved in all 45 (100%). Three patients presented with complications, among them 2 cases (4.4%) of reversible and... PFA is a feasible and safe ablation approach for mitral isthmus ablation in addition to PVI in patients with persistent AF....

Normative Reference Values for FEES and VASES: Preliminary Data From 39 Nondysphagic, Community-Dwelling Adults.

The aim of this study was to establish preliminary reference values for the Visual Analysis of Swallowing Efficiency and Safety (VASES)-a standardized rating methodology used to evaluate swallowing sa... FEES were completed in nondysphagic, community-dwelling adults using a standardized protocol of 15 swallowing trials that varied by bolus size, consistency, contrast agent, and swallowing instructions... Thirty-nine healthy adults completed the study, yielding an analysis of 584 swallows. Swallows were initiated with the bolus in the pharynx for 41.8% of trials. PAS 1 was the most common score, accoun... The results from this study provide preliminary norms for VASES that could be used as a reference when assessing functional swallowing outcomes during FEES. While this is an important first step in es...

Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: preliminary data using a quantitative tool.

The quantification of radiotherapy (RT)-induced functional and morphological brain alterations is fundamental to guide therapeutic decisions in patients with brain tumors. The magnetic resonance imagi... GBM patients treated with RT and subjected to MRI assessment were enrolled. Each patient, pre- and post-RT, undergoes to a qualitative evaluation with global cerebral atrophy (GCA) and medial temporal... A statistically significant strong negative association between the percentage value of the left temporal lobe and the GCA score and the left temporal lobe and the MTA score was found, while a moderat... AI tools can support a correct evaluation of RT-induced brain injuries, allowing an objective and earlier assessment of the brain tissue modifications....

Accompanying mental health problems at home: Preliminary data from a crisis resolution and home treatment team in Catalonia.

WHAT IS KNOWN ON THE SUBJECT?: Home treatment teams help people in a mental health crisis to recover. The staff goes to the person's home, avoiding the need to go to the hospital and providing care in... INTRODUCTION: Crisis resolution and home treatment teams (CRHTTs) provide intensive home care to people in a mental health crisis, becoming an increasingly widespread alternative to hospital admission... To share the organizational functioning, the therapeutic approach, and the outcomes obtained in a CRHTT in Catalonia, Spain.... A descriptive analysis of the functioning of a home treatment team, the characteristics of the people served, and the clinical results from November 2017 to December 2019 are presented.... One hundred and five people were served, with an average stay of 57 days. And 55.24% were women, and the mean age was 41. Most people could overcome the crisis at home, and 5.71% required hospital adm... Despite reduced staff, home care was an alternative to hospital admission for most people treated.... Flexibility, teamwork, and collaboration with the social network are relevant factors when accompanying the recovery process at home....

Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-19.

The goal of this study was to (1) Describe the patient population of a newly implemented addiction medicine consult service (AMCS); (2) Evaluate referrals to community-based addiction support services... A retrospective observational analysis was conducted at Health Sciences North in Sudbury, Ontario, Canada, with a newly implemented AMCS from November 2018 and July 2021. Data were collected using the... A total of 833 unique patients were assessed through the AMCS. A total of 1,294 referrals were made to community-based addiction support services, with the highest proportion of referrals between Augu... Implementation of an AMCS provides a focused service for patients using with substance use disorders. The service resulted in a high referral rate to community-based addiction support services and lim...

Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data.

We explored the brain metabolism correlates of emergent cerebrospinal fluid (CSF) biomarkers in a group of 26 patients with prodromal Alzheimer's disease (AD). Distinct volumes of interest (VOIs) expr...